Matches in Wikidata for { <http://www.wikidata.org/entity/Q91880148> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91880148 description "article scientifique publié en 2018" @default.
- Q91880148 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91880148 description "scientific article published on 22 August 2018" @default.
- Q91880148 description "wetenschappelijk artikel" @default.
- Q91880148 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91880148 name "Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer" @default.
- Q91880148 name "Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer" @default.
- Q91880148 type Item @default.
- Q91880148 label "Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer" @default.
- Q91880148 label "Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer" @default.
- Q91880148 prefLabel "Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer" @default.
- Q91880148 prefLabel "Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer" @default.
- Q91880148 P1433 Q91880148-6C65DF23-7AE8-459E-BA8F-BCE496C2933B @default.
- Q91880148 P1476 Q91880148-FDB2E380-FA6F-4A38-940A-ECFE6D57CFEF @default.
- Q91880148 P2093 Q91880148-04F57BB1-772A-41B7-A992-56116CB17A45 @default.
- Q91880148 P2093 Q91880148-2BB496E8-004B-4931-AA7B-43DF3CCABB57 @default.
- Q91880148 P2093 Q91880148-34BC96C6-6066-43D5-B8B1-D5BE5894FE3E @default.
- Q91880148 P2093 Q91880148-AFC90762-1BCD-44E3-A069-E12BCDFD208B @default.
- Q91880148 P2093 Q91880148-CB761167-F257-4A01-9A24-6D01A8768351 @default.
- Q91880148 P304 Q91880148-72416DAD-DF10-4FEB-B226-2D84FA663C39 @default.
- Q91880148 P31 Q91880148-EB310282-09DC-4B7A-B0E4-23B0361B8A2D @default.
- Q91880148 P356 Q91880148-4AD9D3B6-0BD4-469F-AC8B-0F054CC69126 @default.
- Q91880148 P478 Q91880148-7E5D5CA7-BA5C-40C1-B2C5-D0DD4C10A956 @default.
- Q91880148 P577 Q91880148-E001B6CE-B023-4771-B9B3-04634FE9F9E8 @default.
- Q91880148 P698 Q91880148-C1E81A8C-6141-440B-B806-22CB0956BE09 @default.
- Q91880148 P921 Q91880148-2B292175-D6F7-45FF-9406-6173CC6DDEEC @default.
- Q91880148 P921 Q91880148-F6BB77E7-56EB-40F8-87FA-5E9041E31136 @default.
- Q91880148 P356 J.LUNGCAN.2018.08.018 @default.
- Q91880148 P698 30268469 @default.
- Q91880148 P1433 Q641464 @default.
- Q91880148 P1476 "Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer" @default.
- Q91880148 P2093 "Benjamin Haaland" @default.
- Q91880148 P2093 "Gilberto de Lima Lopes" @default.
- Q91880148 P2093 "Joao P da Silveira Nogueira Lima" @default.
- Q91880148 P2093 "Mina Georgieva" @default.
- Q91880148 P2093 "Pedro Aguiar" @default.
- Q91880148 P304 "248-254" @default.
- Q91880148 P31 Q13442814 @default.
- Q91880148 P356 "10.1016/J.LUNGCAN.2018.08.018" @default.
- Q91880148 P478 "124" @default.
- Q91880148 P577 "2018-08-22T00:00:00Z" @default.
- Q91880148 P698 "30268469" @default.
- Q91880148 P921 Q13896859 @default.
- Q91880148 P921 Q3658562 @default.